The Courtroom Showdown Between Elon Musk and Sam Altman
For the last three weeks, a messy, dramatic battle has played out between two of the most powerful titans of tech in the world: Elon Musk and Sam Altman.
As jury deliberations begin today, the technology reporter Mike Isaac takes us inside the courtroom drama and explains how a corporate dispute got extremely personal.
Guest: Mike Isaac, a New York Times reporter based in the San Francisco Bay Area, covering tech companies and Silicon Valley.
Background reading:
- Inside the courtroom circus with Elon Musk and Sam Altman.
- Musk lawyer’s question for Sam Altman on the stand: Are you trustworthy?
Photo: Manuel Orbegozo/Reuters, Benjamin Fanjoy/Getty Images
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
- Datum:
- Duur:
Meer afleveringen van The Daily
-
A Trump Dissenter Fights for His Political Life
In Kentucky today, amid record-low approval ratings, President Trump is asking Republican primary voters to reject Representative Thomas Massie, who has broken with Mr. Trump on a handful of votes. Instead, he wants them to elect his... -
The Courtroom Showdown Between Elon Musk and Sam Altman
For the last three weeks, a messy, dramatic battle has played out between two of the most powerful titans of tech in the world: Elon Musk and Sam Altman. As jury deliberations begin today, the technology reporter Mike Isaac takes us... -
Can We Reverse Aging?
The quest for a “cure” for aging — a way to remain youthful, even as we get older — is a project as old as humanity. It’s also a big business; products, therapies and treatments intended to moderate or reverse aging are part of a $2...